Mukai Kaori, Obata Kazushige, Tsujimura Yusuke, Karasuyama Hajime
Department of Immune Regulation, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Allergol Int. 2009 Mar;58(1):11-9. doi: 10.2332/allergolint.08-RAI-0059. Epub 2009 Jan 25.
Basophils represent less than 1% of peripheral blood leukocytes. They are often recruited to the site of allergic inflammation, albeit in small numbers. However, it remained uncertain whether basophils play any significant role in allergic reactions or act as minor and redundant 'circulating mast cells'. We have recently demonstrated that basophils play critical roles in systemic anaphylaxis and chronic allergic inflammation, distinctively from mast cells. Basophils are one of the major players in the IgG- but not IgE-mediated systemic anaphylaxis, in contrast to mast cells. In response to the allergen-IgG immune complexes, basophils release the platelet-activating factor rather than histamine as the major chemical mediator to induce the systemic anaphylaxis. The depletion of basophils protects mice from death due to anaphylactic shock. Basophils also play a crucial role in the development of the IgE-mediated chronic allergic inflammation with massive eosinophil infiltration in the skin, independently of T cells and mast cells, even though basophils account for only approximately 2% of the infiltrates. The basophil depletion shows a therapeutic effect on on-going allergic inflammation. Accumulating evidence suggests that basophils function as initiators rather than effectors of the chronic allergic inflammation. Thus, basophils and their products seem to be promising therapeutic targets for allergic disorders.
嗜碱性粒细胞在外周血白细胞中所占比例不到1%。它们常被募集到过敏性炎症部位,尽管数量很少。然而,嗜碱性粒细胞在过敏反应中是否发挥重要作用,或者是否作为次要且多余的“循环肥大细胞”发挥作用,仍不确定。我们最近证明,嗜碱性粒细胞在全身过敏反应和慢性过敏性炎症中发挥关键作用,这与肥大细胞明显不同。与肥大细胞相反,嗜碱性粒细胞是IgG介导而非IgE介导的全身过敏反应的主要参与者之一。在对过敏原-IgG免疫复合物的反应中,嗜碱性粒细胞释放血小板活化因子而非组胺作为主要化学介质来诱导全身过敏反应。嗜碱性粒细胞的耗竭可保护小鼠免于过敏性休克死亡。嗜碱性粒细胞在IgE介导的慢性过敏性炎症的发展中也起着关键作用,这种炎症在皮肤中有大量嗜酸性粒细胞浸润,独立于T细胞和肥大细胞,尽管嗜碱性粒细胞仅占浸润细胞的约2%。嗜碱性粒细胞的耗竭对正在进行的过敏性炎症具有治疗作用。越来越多的证据表明,嗜碱性粒细胞作为慢性过敏性炎症的启动者而非效应者发挥作用。因此,嗜碱性粒细胞及其产物似乎是过敏性疾病有前景的治疗靶点。